Beihai Gofar Chuanshan Biological (600538.SH) director Wu Peicheng plans to spend 2 to 4 million yuan to increase holdings.
Guofa Group (stock code: 600538.SH) announces that Mr. Wu Peicheng, a director of the company, plans to resign from January 20, 2025...
Beihai Gofar Chuanshan Biological (600538.SH) announced that Mr. Wu Peicheng, a director of the company, plans to increase his shareholding in the company through concentrated trading starting from January 20, 2025 for a period of 6 months. The amount of increase shall not be less than 2 million yuan and not exceed 4 million yuan.
Related Articles
US Stock Market Move | Amgen (AMGN.US) rose 6% in trading as third-quarter sales exceeded expectations and the full-year performance guidance was raised.
US Stock Market Move | Concept stocks of encrypted currencies are rising, with Bitcoin back above $103,000.
US Stock Market Move | Tianrui Company (TDC.US) Soars Over 26% with Q3 Performance Exceeding Expectations
US Stock Market Move | Amgen (AMGN.US) rose 6% in trading as third-quarter sales exceeded expectations and the full-year performance guidance was raised.
US Stock Market Move | Concept stocks of encrypted currencies are rising, with Bitcoin back above $103,000.
US Stock Market Move | Tianrui Company (TDC.US) Soars Over 26% with Q3 Performance Exceeding Expectations
RECOMMEND
Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
05/11/2025
Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
05/11/2025
Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
05/11/2025
